Minnesota Pilot Trial Tests State Cannabis Program as a Research Pathway in Advanced Pancreatic Cancer
A pilot randomized trial in Minnesota tested whether a state medical cannabis program can support clinical research, according to a study in JCO Oncology Practice. The waitlist-controlled trial enrolled 32 patients with newly diagnosed advanced pancreatic cancer, randomized to early access (weeks 0–8) or delayed access (weeks 9–16) through the Minnesota Medical Cannabis Program. The








